Anti-diabetic effect of loganin by inhibiting FOXO1 nuclear translocation via PI3K/Akt signaling pathway in INS-1 cell.

Mo, Fang-Fang; Liu, Hai-Xia; Zhang, Yi; Hua, Jing; Zhao, Dan-Dan; An, Tian; Zhang, Dong-Wei; Tian, Tian; Gao, Si-Hua

Mo, Fang-Fang; Liu, Hai-Xia; Zhang, Yi; Hua, Jing; Zhao, Dan-Dan; An, Tian; Zhang, Dong-Wei; Tian, Tian; Gao, Si-Hua.

Affiliation

Mo FF; Beijing University of Chinese Medicine, Beijing, 100029, China.
Liu HX; Beijing University of Chinese Medicine, Beijing, 100029, China.
Zhang Y; Beijing Open University, Beijing, 100081, China.
Hua J; Beijing University of Chinese Medicine, Third Affiliated Hospital, Beijing, 100029, China.
Zhao DD; Beijing University of Chinese Medicine, Beijing, 100029, China.
An T; Beijing University of Chinese Medicine, Beijing, 100029, China.
Zhang DW; Beijing University of Chinese Medicine, Beijing, 100029, China.
Tian T; Beijing University of Chinese Medicine, Beijing, 100029, China.
Gao SH; Beijing University of Chinese Medicine, Beijing, 100029, China.

Iran J Basic Med Sci ; 22(3): 262-266, 2019 Mar.

Article de En | MEDLINE | ID: mdl-31156786

Mots clés

Akt pathway; Factor forkhead box O1-(FOXO1); INS-1 cells; Loganin; Pancreatic ß-cell

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Iran J Basic Med Sci Année: 2019 Type de document: Article Pays d'affiliation: Chine Pays de publication: Iran

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google